regulatory
confidence high
sentiment negative
materiality 0.65
Bio Green Med Solution, Inc. (BGMS): Nasdaq/NYSE listing notice — Cyclacel receives Nasdaq notice for late Q3 10-Q filing; 60 days to submit compliance plan
Bio Green Med Solution, Inc.
- Notice received Nov 21, 2023 for failure to timely file Quarterly Report for period ended Sep 30, 2023.
- Company has 60 calendar days (to Jan 20, 2024) to submit a plan to regain compliance.
- If accepted, Nasdaq may grant up to 180 days (to May 20, 2024) to file the overdue report.
- No immediate effect on listing, but no assurance compliance can be regained.
- Common stock (CYCC) and preferred stock (CYCCP) listed on Nasdaq Capital Market.